Neurocrine Biosciences (NBIX)
(Delayed Data from NSDQ)
$135.45 USD
-0.81 (-0.59%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $135.51 +0.06 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: -- |
6/2024 | $1.04 | 0.00% |
Earnings Summary
For their last quarter, Neurocrine Biosciences (NBIX) reported earnings of $0.42 per share, missing the Zacks Consensus Estimate of $1.04 per share. This reflects a negative earnings surprise of 59.62%. Look out for NBIX's next earnings release expected on August 06, 2024. For the next earning release, we expect the company to report earnings of $1.04 per share, reflecting a year-over-year increase of 9.47%.
Earnings History
Price & Consensus
Zacks News for NBIX
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
NBIX: What are Zacks experts saying now?
Zacks Private Portfolio Services